Herbert Loong, Advisor at Greater Bay Area International Clinical Trial Institute, and Steering Committee Member at Lung Cancer Policy Network, shared a post on LinkedIn:
“Throwback to ESMO TAT Asia26 where we had a dedicated educational session with stellar international faculties including Jayesh Desai, Anna Spreafico and Timothy A. Yap titled “Next generation targeted therapies against oncogenic drivers: New targets and new challenges”.
Happy to share some slides from my talk addressing the challenges and opportunities of pursuing targeted therapy combinations.
Full talk and recording will be available on OncologyPRO!”
Other articles about ESMO TAT Asia26 on OncoDaily.
